The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Neuroinflammation across neurological diseases
Abstract
The brain’s response to injury includes the activation of intrinsic microglia and the influx of leukocytes, collectively constituting neuroinflammation, the “flame” of the brain. Although details differ and matter, neuroinflammation exacerbating neurodegeneration has similarities across multiple sclerosis and other neurological disorders, such as stroke and neurodegenerative diseases. Thus, lessons from successful disease-modifying therapies in multiple sclerosis may provide insights into strategies for modulating neuroinflammation and reducing neural injury in other neurological conditions. In this Review, we discuss these lessons and potential strategies for counteracting neuroinflammation, including taming the microglia-orchestrated brain immune responses that contribute to progressing neuropathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Lecanemab in early Alzheimer's disease
van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Steinmetz, J. D., Seeher, K. M., Schiess, N., Nichols, E., Cao, B., Servili, C., Cavallera, V., Cousin, E., Hagins, H., Moberg, M. E., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00038-3 · Cited by 2,019
Microglia states and nomenclature: A field at its crossroads
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.020 · Cited by 1,973
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606468 · Cited by 1,905
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium, Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., et al. (2019) · Science · doi:10.1126/science.aav7188 · Cited by 1,818
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263
Chamorro, Á., Dirnagl, U., Urra, X., & Planas, A. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00114-9 · Cited by 1,198
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease
Gate, D., Saligrama, N., Leventhal, O., Yang, A. C., Unger, M. S., Middeldorp, J., Chen, K., Lehallier, B., Channappa, D., De Los Santos, M. B., et al. (2020) · Nature · doi:10.1038/s41586-019-1895-7 · Cited by 992
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities
Candelario-Jalil, E., Dijkhuizen, R. M., & Magnus, T. (2022) · Stroke · doi:10.1161/strokeaha.122.036946 · Cited by 953
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30475-6 · Cited by 942
Prass, K., Meisel, C., Höflich, C., Braun, J., Halle, E., Wolf, T., Ruscher, K., Victorov, I. V., Priller, J., Dirnagl, U., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021098 · Cited by 925
Global brain inflammation in stroke
Shi, K., Tian, D.-C., Li, Z.-G., Ducruet, A. F., Lawton, M. T., & Shi, F.-D. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30078-x · Cited by 911
Self-citationClonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Lanz, T. V., Brewer, R. C., Ho, P. P., Moon, J.-S., Jude, K. M., Fernandez, D., Fernandes, R. A., Gomez, A. M., Nadj, G.-S., Bartley, C. M., et al. (2022) · Nature · doi:10.1038/s41586-022-04432-7 · Cited by 908
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Alzheimer’s disease drug development pipeline: 2024
Cummings, J., Zhou, Y., Lee, G., Zhong, K., Fonseca, J., & Cheng, F. (2024) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12465 · Cited by 702
An updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy
Chen, X., Firulyova, M., Manis, M., Herz, J., Smirnov, I., Aladyeva, E., Wang, C., Bao, X., Finn, M. B., Hu, H., et al. (2023) · Nature · doi:10.1038/s41586-023-05788-0 · Cited by 609
Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
Choi, I., Zhang, Y., Seegobin, S. P., Pruvost, M., Wang, Q., Purtell, K., Zhang, B., & Yue, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-15119-w · Cited by 608
Jakimovski, D., Bittner, S., Zivadinov, R., Morrow, S. A., Benedict, R. H., Zipp, F., & Weinstock-Guttman, B. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01473-3 · Cited by 597
Smajić, S., Prada-Medina, C. A., Landoulsi, Z., Ghelfi, J., Delcambre, S., Dietrich, C., Jarazo, J., Henck, J., Balachandran, S., Pachchek, S., et al. (2022) · Brain · doi:10.1093/brain/awab446 · Cited by 590
Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Matheoud, D., Sugiura, A., Bellemare-Pelletier, A., Laplante, A., Rondeau, C., Chemali, M., Fazel, A., Bergeron, J. J., Trudeau, L.-E., Burelle, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.039 · Cited by 582
Wang, S., Mustafa, M., Yuede, C. M., Salazar, S. V., Kong, P., Long, H., Ward, M., Siddiqui, O., Paul, R., Gilfillan, S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200785 · Cited by 549
Hamelin, L., Lagarde, J., Dorothée, G., Leroy, C., Labit, M., Comley, R. A., de Souza, L. C., Corne, H., Dauphinot, L., Bertoux, M., et al. (2016) · Brain · doi:10.1093/brain/aww017 · Cited by 519
Immunopathology of secondary‐progressive multiple sclerosis
Prineas, J. W., Kwon, E. E., Cho, E., Sharer, L. R., Barnett, M. H., Oleszak, E. L., Hoffman, B., & Morgan, B. P. (2001) · Annals of Neurology · doi:10.1002/ana.1255 · Cited by 453
Kinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Microglia and astrocyte dysfunction in parkinson's disease
Kam, T.-I., Hinkle, J. T., Dawson, T. M., & Dawson, V. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105028 · Cited by 389
Transforming the understanding of brain immunity
Castellani, G., Croese, T., Peralta Ramos, J. M., & Schwartz, M. (2023) · Science · doi:10.1126/science.abo7649 · Cited by 386
Immune interventions in stroke
Fu, Y., Liu, Q., Anrather, J., & Shi, F.-D. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.144 · Cited by 383
Self-citationScheiblich, H., Dansokho, C., Mercan, D., Schmidt, S. V., Bousset, L., Wischhof, L., Eikens, F., Odainic, A., Spitzer, J., Griep, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.007 · Cited by 360
Luchetti, S., Fransen, N. L., van Eden, C. G., Ramaglia, V., Mason, M., & Huitinga, I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1818-y · Cited by 355
In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease
Kreisl, W. C., Lyoo, C. H., McGwier, M., Snow, J., Jenko, K. J., Kimura, N., Corona, W., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2013) · Brain · doi:10.1093/brain/awt145 · Cited by 350
Placebo-controlled trial of an oral BTK inhibitor in multiple sclerosis
Montalban, X., Arnold, D. L., Weber, M. S., Staikov, I., Piasecka-Stryczynska, K., Willmer, J., Martin, E. C., Dangond, F., Syed, S., & Wolinsky, J. S. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901981 · Cited by 324
Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation
Xue, M., & Yong, V. W. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30364-1 · Cited by 323
Self-citationImpact of an immune modulator fingolimod on acute ischemic stroke
Fu, Y., Zhang, N., Ren, L., Yan, Y., Sun, N., Li, Y.-J., Han, W., Xue, R., Liu, Q., Hao, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416166111 · Cited by 288
Self-citationEvolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study
Gerhard, A., Schwarz, J., Myers, R., Wise, R., & Banati, R. B. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.09.034 · Cited by 284
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study
Fu, Y., Hao, J., Zhang, N., Ren, L., Sun, N., Li, Y.-J., Yan, Y., Huang, D., Yu, C., & Shi, F.-D. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1065 · Cited by 278
Self-citationCD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J. (2020) · Brain · doi:10.1093/brain/awaa269 · Cited by 267
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Ridker, P. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313129 · Cited by 260
Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances
Bar-Or, A., & Li, R. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00063-6 · Cited by 242
Fransen, N. L., Hsiao, C.-C., van der Poel, M., Engelenburg, H. J., Verdaasdonk, K., Vincenten, M. C. J., Remmerswaal, E. B. M., Kuhlmann, T., Mason, M. R. J., Hamann, J., et al. (2020) · Brain · doi:10.1093/brain/awaa117 · Cited by 229
Elkins, J., Veltkamp, R., Montaner, J., Johnston, S. C., Singhal, A. B., Becker, K., Lansberg, M. G., Tang, W., Chang, I., Muralidharan, K., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30357-x · Cited by 224
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Charabati, M., Wheeler, M. A., Weiner, H. L., & Quintana, F. J. (2023) · Cell · doi:10.1016/j.cell.2023.03.008 · Cited by 222
CD4 + T cells contribute to neurodegeneration in Lewy body dementia
Gate, D., Tapp, E., Leventhal, O., Shahid, M., Nonninger, T. J., Yang, A. C., Strempfl, K., Unger, M. S., Fehlmann, T., Oh, H., et al. (2021) · Science · doi:10.1126/science.abf7266 · Cited by 214
Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain
Rostami, J., Fotaki, G., Sirois, J., Mzezewa, R., Bergström, J., Essand, M., Healy, L., & Erlandsson, A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01776-7 · Cited by 212
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
Singh, S., Metz, I., Amor, S., van der Valk, P., Stadelmann, C., & Brück, W. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1082-0 · Cited by 211
Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30173-4 · Cited by 209
Reich, D. S., Arnold, D. L., Vermersch, P., Bar-Or, A., Fox, R. J., Matta, A., Turner, T., Wallström, E., Zhang, X., Mareš, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00237-4 · Cited by 204
Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations
Liu, Q., Jin, W.-N., Liu, Y., Shi, K., Sun, H., Zhang, F., Zhang, C., Gonzales, R. J., Sheth, K. N., La Cava, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.015 · Cited by 203
Self-citationNeuroinflammatory component of gray matter pathology in multiple sclerosis
Herranz, E., Giannì, C., Louapre, C., Treaba, C. A., Govindarajan, S. T., Ouellette, R., Loggia, M. L., Sloane, J. A., Madigan, N., Izquierdo‐Garcia, D., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24791 · Cited by 200
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., et al. (2024) · Med · doi:10.1016/j.medj.2024.03.002 · Cited by 192
TREM2 dependent and independent functions of microglia in Alzheimer’s disease
Hou, J., Chen, Y., Grajales-Reyes, G., & Colonna, M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00588-y · Cited by 191
tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke
Shi, K., Zou, M., Jia, D.-M., Shi, S., Yang, X., Liu, Q., Dong, J.-F., Sheth, K. N., Wang, X., & Shi, F.-D. (2021) · Circulation Research · doi:10.1161/circresaha.120.317596 · Cited by 189
Self-citationNeuroinflammation and protein pathology in Parkinson’s disease dementia
Kouli, A., Camacho, M., Allinson, K., & Williams-Gray, C. H. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01083-5 · Cited by 189
Microglia in multiple sclerosis: protectors turn destroyers
Yong, V. W. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.023 · Cited by 185
Self-citationZierfuss, B., Larochelle, C., & Prat, A. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00377-0 · Cited by 185
Hamelin, L., Lagarde, J., Dorothée, G., Potier, M. C., Corlier, F., Kuhnast, B., Caillé, F., Dubois, B., Fillon, L., Chupin, M., et al. (2018) · Brain · doi:10.1093/brain/awy079 · Cited by 177
Mechanisms underlying progression in multiple sclerosis
Absinta, M., Lassmann, H., & Trapp, B. D. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000818 · Cited by 175
B cells in central nervous system disease: diversity, locations and pathophysiology
Jain, R. W., & Yong, V. W. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00652-6 · Cited by 175
Self-citationA Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results
(2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181342f32 · Cited by 174
The immune system in Parkinson's disease: what we know so far
Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 173
Kelly, P. J., Lemmens, R., Weimar, C., Walsh, C., Purroy, F. F., Barber, M., Collins, R., Cronin, S., Członkowska, A., Desfontaines, P., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00968-1 · Cited by 173
Innate immune memory after brain injury drives inflammatory cardiac dysfunction
Simats, A., Zhang, S., Messerer, D., Chong, F., Beşkardeş, S., Chivukula, A. S., Cao, J., Besson‐Girard, S., Montellano, F. A., Morbach, C., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.028 · Cited by 170
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis
Yong, H. Y. F., & Yong, V. W. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00581-x · Cited by 163
Self-citationRawji, K. S., Young, A. M. H., Ghosh, T., Michaels, N. J., Mirzaei, R., Kappen, J., Kolehmainen, K. L., Alaeiilkhchi, N., Lozinski, B., Mishra, M. K., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02129-7 · Cited by 153
Self-citationLesion stage-dependent causes for impaired remyelination in MS
Heß, K., Starost, L. J., Kieran, N. W., Thomas, C., Vincenten, M. C. J., Antel, J. P., Martino, G., Huitinga, I., Healy, L. M., & Kuhlmann, T. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02189-9 · Cited by 148
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
Fox, R. J., Bar-Or, A., Traboulsee, A., Oreja-Guevara, C., Giovannoni, G., Vermersch, P., Syed, S., Li, Y., Vargas, W. S., Turner, T. J., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2415988 · Cited by 146
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis
Sucksdorff, M., Matilainen, M., Tuisku, J., Polvinen, E., Vuorimaa, A., Rokka, J., Nylund, M., Rissanen, E., & Airas, L. (2020) · Brain · doi:10.1093/brain/awaa275 · Cited by 142
DNA-sensing inflammasomes cause recurrent atherosclerotic stroke
Cao, J., Roth, S., Zhang, S., Kopczak, A., Mami, S., Asare, Y., Georgakis, M. K., Messerer, D., Horn, A., Shemer, R., et al. (2024) · Nature · doi:10.1038/s41586-024-07803-4 · Cited by 137
Functional immune cell–astrocyte interactions
Sanmarco, L. M., Polonio, C. M., Wheeler, M. A., & Quintana, F. J. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202715 · Cited by 136
Dubois, B., López‐Arrieta, J., Lipschitz, S., Doskas, T. K., Spiru, L., Moroz, S., Venger, O., Vermersch, P., Moussy, A., Mansfield, C. D., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01169-x · Cited by 136
Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury
Holden, S. S., Grandi, F. C., Aboubakr, O., Higashikubo, B., Cho, F. S., Chang, A. H., Forero, A. O., Morningstar, A. R., Mathur, V., Kuhn, L. J., et al. (2021) · Science · doi:10.1126/science.abj2685 · Cited by 133
Tian, D., Shi, K., Zhu, Z., Yao, J., Yang, X., Su, L., Zhang, S., Zhang, M., Gonzales, R. J., Liu, Q., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25352 · Cited by 131
Self-citationThe Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.11.012 · Cited by 131
Schlepckow, K., Morenas‐Rodríguez, E., Hong, S. Y., & Haass, C. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00247-8 · Cited by 131
Molecular Pathogenesis of Ischemic and Hemorrhagic Strokes: Background and Therapeutic Approaches
Maida, C. D., Norrito, R. L., Rizzica, S., Mazzola, M., Scarantino, E. R., & Tuttolomondo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126297 · Cited by 130
Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease
Yan, Y., Zheng, R., Liu, Y., Ruan, Y., Lin, Z., Xue, N., Chen, Y., Zhang, B., & Pu, J. (2023) · Aging Cell · doi:10.1111/acel.13834 · Cited by 128
Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial
Elkind, M. S. V., Veltkamp, R. C., Montaner, J., Johnston, S. C., Singhal, A. B., Becker, K. J., Lansberg, M. G., Tang, W., Kasliwal, R., & Elkins, J. S. (2020) · Neurology · doi:10.1212/wnl.0000000000010038 · Cited by 123
Li, J., Meng, X., Shi, F., Jing, J., Gu, H., Jin, A., Jiang, Y., Li, H., Johnston, S. C., Hankey, G. J., et al. (2024) · BMJ · doi:10.1136/bmj-2023-079061 · Cited by 123
Self-citationBack to the future: oral targeted therapy for RA and other autoimmune diseases
O'Shea, J. J., Laurence, A., & McInnes, I. B. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.7 · Cited by 115
Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome
Giannetti, P., Politis, M., Su, P., Turkheimer, F., Malik, O., Shiva Keihaninejad, A., Wu, K., Waldman, A. D., Reynolds, R., Nicholas, R. S., et al. (2014) · Brain · doi:10.1093/brain/awu331 · Cited by 114
Gulyás, B. Z., Tóth, M., Schain, M., Airaksinen, A. J., Vas, Á., Kostulas, K., Lindström, P., Hillert, J. A., & Halldin, C. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.026 · Cited by 112
Microglial activation, white matter tract damage, and disability in MS
Rissanen, E., Tuisku, J., Vahlberg, T. J., Sucksdorff, M., Paavilainen, T., Parkkola, R. K., Rokka, J., Gerhard, A., Hinz, R., Talbot, P. S., et al. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000443 · Cited by 107
Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB
Chou, T.-W., Chang, N. P., Krishnagiri, M., Patel, A. P., Lindman, M., Angel, J. P., Kung, P.-L., Atkins, C., & Daniels, B. P. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04049-0 · Cited by 104
An autoantibody signature predictive for multiple sclerosis
Zamecnik, C. R., Sowa, G. M., Abdelhak, A., Dandekar, R., Bair, R., Wade, K. J., Bartley, C. M., Kizer, K., Augusto, D. G., Tubati, A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02938-3 · Cited by 104
Keaney, J., Gasser, J., Gillet, G., Scholz, D., & Kadiu, I. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09839-0 · Cited by 98
T cell interactions with microglia in immune-inflammatory processes of ischemic stroke
Zheng, Y., Ren, Z., Liu, Y., Yan, J., Chen, C., He, Y., Shi, Y., Cheng, F., Wang, Q., Li, C., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01385 · Cited by 97
Montalbán, X., Vermersch, P., Arnold, D. L., Bar‐Or, A., Cree, B., Cross, A. H., Havrdová, E., Kappos, L., Stüve, O., Wiendl, H., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00328-4 · Cited by 97
Formyl peptide receptor 1 signaling potentiates inflammatory brain injury
Li, Z., Li, Y., Han, J., Zhu, Z., Li, M., Liu, Q., Wang, Y., & Shi, F. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe9890 · Cited by 93
Self-citationMoutinho, M., Puntambekar, S. S., Tsai, A. P., Coronel, I., Lin, P. B., Casali, B. T., Martinez, P., Oblak, A. L., Lasagna-Reeves, C. A., Lamb, B. T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl7634 · Cited by 92
Beuker, C., Strecker, J., Rawal, R., Schmidt‐Pogoda, A., Ruck, T., Wiendl, H., Klotz, L., Schäbitz, W., Sommer, C., Minnerup, H., et al. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00887-4 · Cited by 91
Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment
Hernández‐Jiménez, M., Abad‐Santos, F., Cotgreave, I. A., Gállego, J., Jilma, B., Flores, A., Jovin, T. G., Vivancos, J., Hernández‐Pérez, M., Molina, C. A., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.1660 · Cited by 91
Sykora, M., Šiarnik, P., Diedler, J., Collaborators, V. A., Lees, K. R., Alexandrov, A. V., Bath, P. M., Bluhmki, E., Bornstein, N. M., Claesson, L., et al. (2015) · Stroke · doi:10.1161/strokeaha.114.008260 · Cited by 89
Pereira, J. B., Janelidze, S., Strandberg, O. T., Whelan, C. D., Zetterberg, H., Blennow, K., Palmqvist, S., Stomrud, E., Mattsson, N., & Hansson, O. (2022) · Nature Aging · doi:10.1038/s43587-022-00310-z · Cited by 89
Chronic effects of inflammation on tauopathies
Langworth-Green, C., Patel, S., Jaunmuktane, Z., Jabbari, E., Morris, H. R., Thom, M., Lees, A. J., Hardy, J., Zandi, M. S., & Duff, K. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00038-8 · Cited by 86
Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation
van den Bosch, A. M. R., van der Poel, M., Fransen, N. L., Vincenten, M. C. J., Bobeldijk, A. M., Jongejan, A., Engelenburg, H. J., Moerland, P. D., Smolders, J., Huitinga, I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46068-3 · Cited by 82
Mullin, S., Stokholm, M. G., Hughes, D. A., Mehta, A. B., Parbo, P., Hinz, R., Pavese, N., Brooks, D. J., & Schapira, A. H. V. (2019) · Movement Disorders · doi:10.1002/mds.28375 · Cited by 81
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
Oh, J., Arnold, D. L., Cree, B., Ionete, C., Kim, H.-J., Sormani, M. P., Syed, S., Chen, Y., Maxwell, C. R., Benoit, P., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2415985 · Cited by 80
Wang, P., Luo, M., Zhou, W., Jin, X., Xu, Z., Yan, S., Li, Y., Xu, C., Cheng, R., Huang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.814239 · Cited by 77
Neuroinflammation is linked to dementia risk in Parkinson’s disease
Kouli, A., Spindler, L. R. B., Fryer, T. D., Hong, Y. T., Malpetti, M., Aigbirhio, F. I., White, S. R., Camacho, M., O'Brien, J. T., & Williams‐Gray, C. H. (2023) · Brain · doi:10.1093/brain/awad322 · Cited by 77
Waste clearance shapes aging brain health
Jiang-Xie, L.-F., Drieu, A., & Kipnis, J. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.017 · Cited by 75
MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response
Pellerin, K., Rubino, S. J., Burns, J. C., Smith, B. A., McCarl, C., Zhu, J. K., Jandreski, L., Cullen, P. F., Carlile, T. M., Li, A., et al. (2021) · Brain · doi:10.1093/brain/awab231 · Cited by 69
STING signaling in the brain: Molecular threats, signaling activities, and therapeutic challenges
Yang, K., Tang, Z., Xing, C., & Yan, N. (2023) · Neuron · doi:10.1016/j.neuron.2023.10.014 · Cited by 69
Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies
Zhang, P., & Gao, F. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10877-z · Cited by 67
Adaptive immune changes associate with clinical progression of Alzheimer’s disease
van Olst, L., Kamermans, A., Halters, S., van der Pol, S. M. A., Rodríguez, E., Verberk, I. M. W., Verberk, S. G. S., Wessels, D. W. R., Rodriguez-Mogeda, C., Verhoeff, J., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00726-8 · Cited by 64
Yang, H., Teng, L., Kang, D., Menon, V., Ge, T., Finucane, H. K., Schultz, A. P., Properzi, M. J., Klein, H., Chibnik, L. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43132-2 · Cited by 61
Microglia: Friend and foe in tauopathy
Odfalk, K. F., Bieniek, K. F., & Hopp, S. C. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102306 · Cited by 60
Rossano, S. M., Johnson, A. S., Smith, A. P., Ziaggi, G., Roetman, A. E., Guzman, D., Okafor, A., Klein, J., Tomljanovic, Z., Stern, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13699 · Cited by 59
BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair
Geladaris, A., Torke, S., Saberi, D., Alankus, Y. B., Streit, F., Zechel, S., Stadelmann, C., Fischer, A., Boschert, U., Häusler, D., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02730-0 · Cited by 59
Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage
Li, Y.-J., Chang, G., Liu, Y., Gong, Y., Yang, C., Wood, K., Shi, F., Fu, Y., & Yan, Y. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1532-2 · Cited by 57
Self-citationMorris, R. S., Jones, P. S., Alawneh, J., Hong, Y. T., Fryer, T. D., Aigbirhio, F. I., Warburton, E. A., & Baron, J. (2018) · Brain · doi:10.1093/brain/awy121 · Cited by 57
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
Aguzzoli, C. S., Ferreira, P. C. L., Povala, G., Ferrari‐Souza, J. P., Bellaver, B., Soares, C., Zalzale, H., Lussier, F. Z., Rohden, F., Abbas, S., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.45175 · Cited by 57
Koch, M., Zabad, R., Giuliani, F., Hader, W., Lewkonia, R., Metz, L., & Yong, W. V. (2015) · Journal of Neurological Sciences · doi:10.1016/j.jns.2015.08.1525 · Cited by 49
Greenland, J. C., Cutting, E., Kadyan, S., Bond, S. J., Chhabra, A., & Williams‐Gray, C. H. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040527 · Cited by 49
Lutterotti, A., Hayward-Koennecke, H. K., Sospedra, M., & Martinꝉ, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640935 · Cited by 49
Allanach, J. R., Farrell, J. W., Mésidor, M., & Karimi‐Abdolrezaee, S. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211008760 · Cited by 46
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology: A Review
Ismail, F. S., Gallus, M., Meuth, S. G., Okada, H., Hartung, H.-P., & Melzer, N. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.3818 · Cited by 46
Hydroxychloroquine for Primary Progressive Multiple Sclerosis
Koch, M. W., Kaur, S., Sage, K., Kim, J., Levesque‐Roy, M., Cerchiaro, G., Yong, V. W., Cutter, G., & Metz, L. M. (2021) · Annals of Neurology · doi:10.1002/ana.26239 · Cited by 44
Self-citationPINK1 is a target of T cell responses in Parkinson’s disease
Williams, G. P., Freuchet, A., Michaelis, T., Frazier, A., Tran, N. K., Lima-Júnior, J. R., Phillips, E. J., Mallal, S. A., Litvan, I., Goldman, J. G., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180478 · Cited by 39
Spatially resolved gene signatures of white matter lesion progression in multiple sclerosis
Alsema, A. M., Wijering, M. H. C., Miedema, A., Kotah, J. M., Koster, M., Rijnsburger, M., van Weering, H. R. J., de Vries, H. E., Baron, W., Kooistra, S. M., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01765-6 · Cited by 38
Conte, C., Ingrassia, A. M. T., Brevé, J. J. P., Bol, J. G. J. M., Huisman, E., van Dam, A., Beccari, T., & van de Berg, W. D. J. (2023) · Cells · doi:10.3390/cells12101368 · Cited by 36
Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging
Dong, Y., Jain, R. W., Lozinski, B. M., D’Mello, C., Visser, F., Ghorbani, S., Zandee, S., Brown, D. I., Prat, A., Xue, M., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00205-z · Cited by 32
Self-citationModern Approaches to Evacuating Intracerebral Hemorrhage
Bhatia, K., Hepburn, M., Ziu, E., Siddiq, F., & Qureshi, A. I. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1078-4 · Cited by 28
de Jonge, J. C., Sluis, W. M., Reinink, H., Bath, P. M., Woodhouse, L. J., Zweedijk, B., van de Beek, D., Aamodt, A. H., Alpers, I., Ciccone, A., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100782 · Cited by 27
Langlois, J., Lange, S., Ebeling, M., Macnair, W., Schmucki, R., Li, C., DeGeer, J., Sudharshan, T. J. J., Yong, V. W., Shen, Y. A., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03267-5 · Cited by 26
Self-citationExploring the link between dystrophic microglia and the spread of Alzheimer's neuropathology
Shahidehpour, R. K., Nelson, P. T., Katsumata, Y., & Bachstetter, A. D. (2024) · Brain · doi:10.1093/brain/awae258 · Cited by 22
Sun, Q., Li, Y., & Ning, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-67890-1 · Cited by 17
Mechanism and application of immune interventions in intracerebral haemorrhage
Xu, X., Li, Y., Chen, S., Wu, X., Li, J., Li, G., & Tang, Z. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.22 · Cited by 14
Microglial Inflammatory Mechanisms in Stroke: The Jury Is Still Out
Benkő, S., & Dénes, Á. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.02.007 · Cited by 9
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Zujovic (2000) · doi:10.1002/(sici)1098-1136(20000215)29:4
Metadata
- Authors
- Shi, F.-D., & Yong, V. W.
- Venue
- Science
- Published
- 2025-06-19
- Volume
- 388
- Issue
- 6753
- Pages
- eadx0043-eadx0043
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4411505752
- Cited by
- 274
- References
- 144
- FWCI
- 81.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.